Maria Koehler - Dec 20, 2022 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
EVP, Chief Medical Officer
Signature
/s/ Steve Forte, Attorney-in-Fact
Stock symbol
RPTX
Transactions as of
Dec 20, 2022
Transactions value $
$100,040
Form type
4
Date filed
12/20/2022, 07:05 PM
Previous filing
Jun 13, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Options Exercise $99.9K +48.5K +47.97% $2.06* 149K Dec 20, 2022 Direct
transaction RPTX Common Shares Options Exercise $124 +51 +0.03% $2.43* 150K Dec 20, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -48.5K -52.17% $0.00 44.4K Dec 20, 2022 Common Shares 48.5K $2.06 Direct F1
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -51 -0.05% $0.00 111K Dec 20, 2022 Common Shares 51 $2.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the shares subject to the option vested on May 1, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F2 Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.